SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.660-2.4%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: HardToFind who wrote (12773)5/23/2020 1:36:36 PM
From: RoadyHD  Read Replies (2) of 12871
 
Thanks, good luck to you too. I'm well aware of the TheraCour terms and the risks of this investment. There are reasons this company is still a micro-cap. They are the same reasons the management support team and board have been revolving doors. If NNVC can't get traction now with all eyes on antiviral therapies, they never will. They have just raised a year's worth of funding capital. But it is the next three months that are telling: an IND and a CV collaboration just happen. The CDA was a good start. The disclosure that the IND is being delayed due to the pandemic was not.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext